Cargando…

Prescription Filling Patterns of Evidence-Based Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States

BACKGROUND: Maintaining a steady medication supply during a public health crisis is a major health priority. We leveraged a large U.S. pharmacy-claims database to understand the use of evidence-based therapies in heart failure (HF) care during the coronavirus disease-2019 (COVID-19) pandemic. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaduganathan, Muthiah, Li, Diane, Van Meijgaard, Jeroen, Warraich, Haider J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570423/ https://www.ncbi.nlm.nih.gov/pubmed/34214650 http://dx.doi.org/10.1016/j.cardfail.2021.06.013

Ejemplares similares

Early vs late filling of new heart failure prescription and its association with avoidable hospital admissions
por: Poonawalla, Insiya B, et al.
Publicado: (2023)

A rationale for dedicated trials of combination therapy in heart failure
por: Blumer, Vanessa, et al.
Publicado: (2022)

Prescription fill patterns for benzodiazepine and opioid drugs during the COVID-19 pandemic in the United States
por: de Dios, Constanza, et al.
Publicado: (2021)

Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018
por: Salah, Husam M., et al.
Publicado: (2022)

Innovation in Ambulatory Care of Heart Failure in the Era of Coronavirus Disease 2019
por: Leiva, Orly, et al.
Publicado: (2020)

What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?
por: Khan, Muhammad Shahzeb, et al.
Publicado: (2020)

Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction
por: Ostrominski, John W., et al.
Publicado: (2022)

Impact of the Coronavirus Disease 2019 Pandemic on Outpatient Antibiotic Prescriptions in the United States
por: Buehrle, Deanna J, et al.
Publicado: (2020)

Trends in Filled Naloxone Prescriptions Before and During the COVID-19 Pandemic in the United States
por: O’Donoghue, Ashley L., et al.
Publicado: (2021)

Age at Diagnosis of Heart Failure in United States Veterans With and Without HIV Infection
por: Erqou, Sebhat, et al.
Publicado: (2021)

Concomitant Filled Prescriptions of Oxymorphone or Oxycodone with CYP3A Inhibitors and Inducers
por: Coyle, D. Tyler, et al.
Publicado: (2020)

Out-of-Pocket Costs for SGLT-2 (Sodium-Glucose Transport Protein-2) Inhibitors in the United States
por: Aggarwal, Rahul, et al.
Publicado: (2021)

Association of Prescription Co-payment With Adherence to Glucagon-Like Peptide-1 Receptor Agonist and Sodium-Glucose Cotransporter-2 Inhibitor Therapies in Patients With Heart Failure and Diabetes
por: Essien, Utibe R., et al.
Publicado: (2023)

Recent trends in prescription drug misuse in the United States by age, race/ethnicity, and sex
por: Schepis, Ty S., et al.
Publicado: (2022)

Hospice Use Among Patients with Heart Failure
por: Cross, Sarah H, et al.
Publicado: (2019)

Reductions in Heart Failure Hospitalizations During the COVID-19 Pandemic
por: HALL, MICHAEL E., et al.
Publicado: (2020)

Impact of the COVID-19 Pandemic on Cardiovascular Health in 2020: JACC State-of-the-Art Review
por: Roth, Gregory A., et al.
Publicado: (2022)

Comparison of Machine Learning Methods With Traditional Models for Use of Administrative Claims With Electronic Medical Records to Predict Heart Failure Outcomes
por: Desai, Rishi J., et al.
Publicado: (2020)

Interpreting Nonrandomized Evidence for Clinical Decision Making in Cardio-Oncology
por: Chatur, Safia, et al.
Publicado: (2023)

Evidence and Current Use of Levosimendan in the Treatment of Heart Failure: Filling the Gap
por: Conti, Nicolina, et al.
Publicado: (2021)

TRENDS AND FACTORS ASSOCIATED WITH PLACE OF DEATH AMONG INDIVIDUALS WITH CARDIOVASCULAR DISEASE IN THE UNITED STATES
por: Cross, Sarah H, et al.
Publicado: (2019)

Trends in Stimulant Prescription Fills Among Commercially Insured Children and Adults — United States, 2016–2021
por: Danielson, Melissa L., et al.
Publicado: (2023)

Time to Clinical Benefit of Dapagliflozin in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial
por: Vaduganathan, Muthiah, et al.
Publicado: (2022)

Opioid prescription patterns among radiation oncologists in the United States
por: Huang, Tina Q., et al.
Publicado: (2020)

Heart transplantation for COVID-19 myopathy in the United States
por: Gill, George, et al.
Publicado: (2023)

Association of Antidepressant Prescription Filling With Treatment Indication and Prior Prescription Filling Behaviors and Medication Experiences
por: Wong, Jenna, et al.
Publicado: (2022)

Demographic factors associated with dietary supplement prescriptions filled by United States Military Service Members 2005–2013
por: Knapik, Joseph J., et al.
Publicado: (2017)

Impact of COVID-19 on Heart Failure Clinical Trials: Insights From the Heart Failure Collaboratory
por: Bhatt, Ankeet S., et al.
Publicado: (2023)

National Trends in Smoking Cessation Medication Prescriptions for Smokers With Chronic Obstructive Pulmonary Disease in the United States, 2007-2012
por: Kwak, Min Ji, et al.
Publicado: (2018)

Acute Cardiovascular Complications of COVID-19: The High Risk of Underlying Heart Disease
por: Mensah, George A., et al.
Publicado: (2023)

Clinical Outcomes in Patients With Heart Failure Hospitalized With COVID-19
por: Bhatt, Ankeet S., et al.
Publicado: (2021)

Modeling of the Temporal Patterns of Fluoxetine Prescriptions and Suicide Rates in the United States
por: Milane, Michael S, et al.
Publicado: (2006)

Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
por: Duvalyan, Angela, et al.
Publicado: (2021)

The Intersection of Type 2 Myocardial Infarction and Heart Failure
por: McCarthy, Cian P., et al.
Publicado: (2021)

Antimicrobial use in Sweden during the COVID-19 pandemic: prescription fill and inpatient care requisition patterns
por: Nakitanda, Aya Olivia, et al.
Publicado: (2022)

Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid–Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout: A Patient-Level Pooled Meta-analysis of DAPA-HF and DELIVER
por: Butt, Jawad H., et al.
Publicado: (2023)

Response to Comment on Segar et al. Machine Learning to Predict the Risk of Incident Heart Failure Hospitalization Among Patients With Diabetes: The WATCH-DM Risk Score. Diabetes Care 2019;42:2298–2306
por: Segar, Matthew W., et al.
Publicado: (2020)

Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER Trial
por: Peikert, Alexander, et al.
Publicado: (2023)

Bias in natriuretic peptide-guided heart failure trials: time to improve guideline adherence using alternative approaches
por: Stienen, Susan, et al.
Publicado: (2020)

The Prescription Pattern of Heart Failure Medications in Reduced, Mildly Reduced, and Preserved Ejection Fractions
por: Rastogi, Tripti, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ti998u7ifnqv2fnu1f24frdigi